Trends & Ideas: Stocking Up For The Diabetes Epidemic

SP Capital IQ |

S&P Capital IQ Equity Analyst Herman Saftlas joins Brian Egli, S&P Capital IQ Editorial, to discuss diabetes and where investment opportunities might lie with companies that are fighting this disease such as Johnson & Johnson (JNJ) . To read this and all Trends & Ideas content, please visit www.marketscope.com.

 



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
JNJ Johnson & Johnson 121.76 -0.11 -0.09 6,021,721 Trade
SGGHD Signature Group Hldgs New n/a n/a n/a 0

Comments

Emerging Growth

Goldrea Resources Corp.

Goldrea Resources Corp is engaged in the acquisition, exploration and development of mineral properties located in North America.

Private Markets

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…